CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MWG-Biotech AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MWG-Biotech AG
Anzinger Str. 7a
Phone: +49 8092 8289-985p:+49 8092 8289-985 Ebersberg, D-85560  Germany Ticker: NWUNWU
This company is no longer actively traded on any major stock exchange.
Business Summary
MWG-Biotech AG is a German company that offers a range of genomic products and services. The Company's main business activity is the provision of deoxyribonucleic acid (DNA) sequencing, oligonucleotides and DNA/siRNA synthesis products, as well as Custom DNA Sequencing and Next Generation Sequencing services. In addition, the Company offers molecular biological services and scientific consultancy, such as oligo design project services, mutagenesis, cloning and microsatellite analysis, among others. In its siRNA portfolio, the Company offers, in addition to a range of siRNA products, a series of advanced siRNA design tools and other siRNA services. The Company offers its services for academic and industrial research.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/200912/31/2008Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Supervisory Board, Chief Financial Officer of Eurofins Scientific Group Matthias-WilburWeber 5/9/2005 5/9/2005
Spokesman of the Management Board FlorianHeupel 12/15/2008 10/1/2007
Member of the Management Board ElisabethSchroeter 12/1/2008 12/1/2008
3 additional Officers and Directors records available in full report.

Business Names
Business Name
MWG-Biotech AG
NWU

General Information
Number of Employees: 122 (As of 12/31/2008)
Outstanding Shares: 13,308,468 (As of 6/30/2009)
Shareholders: 90,407
Stock Exchange: ETR
Fax Number: +49 8092 21084


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023